Closed iniencephaly is a rare genetic/congenital condition that affects how the head, neck, and upper spine form before birth. Features can include a very short neck, the head tilted backward, and a curved upper spine, and doctors may also see defects of the skull or skin over the spine. It is recognized in pregnancy or at birth, and the course is not compatible with long-term survival in most cases. Care focuses on supportive measures at delivery, and some families discuss comfort-focused care with their team. Genetic counseling is often offered, and prenatal imaging helps understand the extent of closed iniencephaly.
Overview
Closed iniencephalySymptoms
Closed iniencephaly is usually recognized on prenatal ultrasound or at birth. Features include a very short or absent neck, the head fixed backward, and severe spine and skull malformations covered by skin. Breathing difficulties and other organ anomalies are common.
Outlook and prognosis
Most pregnancies with closed iniencephaly end early or have severe complications at birth. For babies who survive delivery, breathing and feeding problems are common, and life is usually very short. Care typically focuses on comfort and family support.
Causes and risk factors
Closed iniencephaly reflects combined genetic and early‑pregnancy factors. Risk factors for closed iniencephaly include low folate, pregestational diabetes, obesity, anti-seizure medicines such as valproate, early‑pregnancy high fever or heat exposure, chromosomal anomalies, and a prior neural‑tube–affected pregnancy.
Genetic influences
Genetics plays a major role in Closed iniencephaly, though most cases are sporadic. Variants affecting neural tube formation, folate pathways, and vertebral development can increase risk. Family history slightly raises recurrence risk; preconception folic acid reduces risk.
Diagnosis
Closed iniencephaly is usually recognized on prenatal ultrasound, then confirmed with targeted fetal MRI or postnatal imaging that shows characteristic head–spine findings. Doctors may add genetic tests to clarify causes; diagnosis of Closed iniencephaly relies on clinical features.
Treatment and drugs
Care centers tailor treatment for closed iniencephaly to the baby’s needs before and after birth. Plans may involve maternal–fetal monitoring, delivery planning, and newborn supportive care with breathing, feeding, and temperature support; surgery is individualized and rare. Multidisciplinary teams guide decisions and comfort-focused care.
Symptoms
Newborns may have a very short neck and a fixed backward tilt of the head that limits movement. Closed iniencephaly affects how the back of the head, neck, and upper spine form before birth. Clinicians call this retroflexion, which means the head tilts sharply backward. Early features of Closed iniencephaly are often seen on prenatal ultrasound, and care teams discuss what support may be needed at delivery.
The head rests tilted far backward, with the face turned upward. This position is usually fixed and does not change with gentle repositioning. It can make basic care tasks, like cradling or positioning, more challenging.
The neck may look extremely short or absent. This comes from differences in how the bones at the skull base and upper spine formed. Skin folds can be visible where a neck would normally be.
Turning the head or tucking the chin toward the chest is very limited. You might notice little to no nodding motion. This stiffness reflects bone changes rather than tight muscles.
In Closed iniencephaly, some upper spine bones can be fused or shaped differently. This creates a rigid neck and an unusually curved upper back. It can affect comfort and positioning.
How people usually first notice Closed iniencephaly?
Families usually first learn about iniencephaly during pregnancy, when a routine ultrasound shows severe head, neck, and spine differences along with too much amniotic fluid (polyhydramnios). These first signs of iniencephaly may also be flagged on maternal blood screening or a detailed anatomy scan, and doctors often confirm the findings with targeted ultrasound or fetal MRI. In rare cases without prenatal care, how iniencephaly is first noticed is at birth, when the baby has a markedly short, fixed neck with the head severely tilted backward due to spinal malformation.
Types of Closed iniencephaly
Closed iniencephaly is a rare congenital neural tube defect present from birth, so clinicians talk about recognized clinical variants rather than symptom “types.” These variants reflect how the back of the head, neck, and spine form, and they can change how severe the symptoms are and which organs are affected. People may notice different sets of symptoms depending on their situation. When reading about types of iniencephaly, you’ll often see two main clinical variants described in textbooks and case series.
Iniencephalus apertus
This variant includes a small opening at the back of the skull with brain tissue protruding outward. The neck is extremely shortened with the head tilted backward, and the spine shows severe bending.
Iniencephalus clausus
This closed form lacks an external brain sac but still has the same extreme backward tilt of the head, very short neck, and marked spinal curvature. Symptoms can range based on how much the skull base and upper spine are malformed.
What genetics can tell you about symptoms
Some genetic changes disrupt how the skull and upper spine close early in pregnancy, leading to closed iniencephaly with a fixed backward-tilted head, short neck, and bent spine. Variants affecting neural tube closure genes can also cause breathing problems, feeding difficulty, and early pregnancy loss.
Causes and risk factors
Closed iniencephaly happens when the neural tube does not close properly very early in pregnancy. It is usually multifactorial, with genes and prenatal influences acting together. Common risk factors for closed iniencephaly include low folate around conception, poorly controlled diabetes, and certain anti-seizure medicines such as valproate. Obesity, high fevers or heat exposure in early pregnancy, and a prior pregnancy or family history of a neural tube defect can also raise risk. Not everyone with the same risk develops the condition.
Environmental and biological risk factors
Closed iniencephaly is a rare condition that begins very early in fetal development. Doctors often group risks into internal (biological) and external (environmental). Below are environmental risk factors for Closed iniencephaly alongside biological factors related to the pregnancy.
Preexisting diabetes in the mother is linked to a higher chance of neural tube defects. Risk appears greatest when blood sugar is high in very early pregnancy. This pattern has been reported with Closed iniencephaly.
A sustained high fever in the earliest weeks of pregnancy has been associated with neural tube defects. Heat stress that raises core body temperature may add to this risk.
Certain medicines that affect fetal development, such as valproate, isotretinoin, or methotrexate, have been linked to neural tube defects. Exposure near conception may increase the likelihood of Closed iniencephaly. Decisions about these medicines should be individualized with your healthcare team.
Exposure to high doses of ionizing radiation early in pregnancy can disrupt neural tube closure. Routine diagnostic imaging is typically low dose, but significant exposure increases risk.
Genetic risk factors
Genetics can influence the chance of Closed iniencephaly in a pregnancy. Most cases are sporadic, but certain inherited patterns and chromosomal changes have been reported. Understanding genetic risk factors for closed iniencephaly can support counseling before or after a pregnancy. Carrying a genetic change doesn’t guarantee the condition will appear.
Family history: Having a previous pregnancy or close relative with a neural tube defect slightly increases the chance of closed iniencephaly. Recurrence risk after one affected pregnancy is about 2–5%.
Chromosomal changes: In some pregnancies, closed iniencephaly occurs with extra or missing chromosome material. Reported examples include trisomy 13 or 18, though this is not present in most cases.
Folate-pathway genes: Variants in genes that process folate, such as MTHFR or MTRR, have been tied to a small increase in overall neural tube defect risk in some studies. These variants in the pregnant person or the fetus do not determine the outcome, but they may contribute alongside other genetic factors.
Cell polarity genes: Changes in genes that guide early neural tube shaping (for example VANGL1, VANGL2, or CELSR1) have been found in some families with neural tube defects. Their effect seems modest on their own and can vary between individuals.
Polygenic background: Rather than a single mutation, many small genetic differences can add up to influence risk. This helps explain why closed iniencephaly can appear in a family without a clear single-gene cause.
Fetal sex: Neural tube defects are reported more often in female fetuses. The reason is not fully understood, but sex-linked biology likely plays a role.
Rare single-gene causes: Very rarely, closed iniencephaly may be part of a broader genetic syndrome that affects early skull and spine development. When present, these syndromes often show other structural differences on ultrasound.
Lifestyle risk factors
Closed iniencephaly is a congenital neural tube defect; lifestyle habits do not cause it. However, certain preconception and early‑pregnancy habits can influence the chance that it occurs. Below are lifestyle risk factors for Closed iniencephaly and how lifestyle affects Closed iniencephaly risk in practical terms.
Not getting enough folic acid before conception and in the first 4–6 weeks of pregnancy increases the chance of neural tube defects like closed iniencephaly. Taking a daily folic acid supplement before pregnancy and through the first trimester lowers this risk.
Diets very low in B12 (for example, vegan diets without B12 supplementation) are linked to higher neural tube defect risk, including closed iniencephaly. Ensuring adequate B12 intake before and early in pregnancy may reduce this risk.
Higher body weight before conception is associated with an increased risk of neural tube defects such as closed iniencephaly. Gradual, sustainable weight management before pregnancy can help lower that risk.
Suboptimal blood sugar control around conception raises the risk of neural tube defects, including closed iniencephaly. Nutrition, physical activity, and medical management that achieve tight preconception glycemic control can reduce this risk.
Risk prevention
Closed iniencephaly develops very early in pregnancy, so prevention focuses on steps taken before conception and in the first weeks after a missed period. Prevention is about lowering risk, not eliminating it completely. The most effective actions are getting enough folic acid, planning pregnancy care, reviewing medications, and managing health conditions that can raise the chance of neural tube defects. Early prenatal screening can’t prevent closed iniencephaly but can identify it sooner for informed decisions and specialist support.
Take a folic acid supplement of at least 400 micrograms (0.4 mg) every day, starting at least 1 month before pregnancy and through the first 12 weeks. This lowers the risk of neural tube defects, including closed iniencephaly. Use a prenatal vitamin with folic acid if possible.
If you’ve had a prior pregnancy affected by a neural tube defect or take certain anti-seizure medicines, your doctor may recommend 4 mg (4,000 micrograms) of folic acid daily before and early in pregnancy. Talk to your doctor about which preventive steps are right for you. Never start high-dose folate without medical guidance.
If you live with diabetes, aim for good glucose control before conception and in the first trimester. Steady blood sugars reduce the chance of neural tube defects like closed iniencephaly. Preconception counseling can help set targets and adjust treatment safely.
Some medicines, such as valproate or folate-blocking drugs, can raise neural tube defect risk. Before pregnancy, review every prescription and over‑the‑counter medicine with your clinician to see if safer alternatives are appropriate. Never stop a needed medicine suddenly without medical advice.
Transmission
Closed iniencephaly is a congenital condition present at birth; it isn’t contagious and can’t be spread from one person to another. Most cases occur as a one-time event very early in pregnancy due to a mix of genetic and environmental influences, rather than being passed down in a simple, predictable way. Rarely, closed iniencephaly is linked to chromosome changes or inherited variants, so families with a prior affected pregnancy may have a slightly higher chance in a future pregnancy. A genetics professional can explain how Closed iniencephaly is inherited, review your family history, and discuss options for planning a future pregnancy.
When to test your genes
Consider genetic testing when there’s a prior pregnancy or close relative with neural tube defects, you’ve had second-trimester loss with severe spine/skull anomalies, or you and your partner are consanguineous. Testing can clarify recurrence risk and guide folate dosing and prenatal screening. Seek preconception counseling if planning pregnancy.
Diagnosis
Closed iniencephaly is usually identified by how the head, neck, and upper spine look on prenatal imaging, with confirmation from detailed scans. The diagnosis of Closed iniencephaly is often made during pregnancy, and sometimes features are clearer as the pregnancy progresses. Early and accurate diagnosis can help you plan ahead with confidence.
Sonographers look for a markedly tilted-back head, a very short neck, and abnormal joining of the skull base and upper spine. These clinical features on ultrasound often point strongly toward Closed iniencephaly.
Your provider may suggest MRI to look closer. MRI provides detailed images of the brain, spine, and soft tissues, helping confirm findings and rule out similar conditions.
Alpha-fetoprotein (AFP) can be elevated with open neural tube defects, but may be normal in Closed iniencephaly because the skin covers the defect. Results guide imaging rather than make the diagnosis on their own.
After birth, doctors assess head position, neck mobility, and overall body alignment. These clinical features can support the prenatal impression and guide immediate care decisions.
Stages of Closed iniencephaly
Closed iniencephaly does not have defined progression stages. It is a structural difference present from very early in fetal development, so it doesn’t unfold in steps over time; care focuses on detecting it and discussing options. There are no early symptoms of closed iniencephaly for the pregnant person; it’s usually identified through prenatal imaging such as detailed ultrasound, sometimes followed by fetal MRI for clarification. Early and accurate diagnosis helps you plan ahead with confidence.
Outlook and prognosis
For many living with closed iniencephaly, the outlook depends on how severe the spine and skull differences are and whether other organs are affected. The condition is rare, and published reports are limited, so doctors often draw on small case series. Everyone’s journey looks a little different. Some babies survive the newborn period, especially when the brain is relatively preserved and breathing and feeding can be supported, but others face life‑threatening challenges at birth.
Looking at the long-term picture can be helpful. Compared with the open form, closed iniencephaly tends to have a better chance of short‑term survival, yet it still carries a high risk of complications such as breathing problems, difficulty swallowing, and limited neck movement. Early symptoms of closed iniencephaly may include stiff backward head positioning and troubles with feeding, which can lead to poor weight gain without careful support. If heart, kidney, or other brain differences are also present, overall prognosis is more guarded.
Prognosis refers to how a condition tends to change or stabilize over time. Some children with milder closed iniencephaly can live into childhood and beyond with multidisciplinary care, including respiratory support, nutrition planning, and physical therapy, though motor delays and mobility limits are common. Mortality is highest in the first days to weeks of life when severe brain or airway issues are present; when those are manageable, survival improves, but long‑term independence is uncommon. With ongoing care, many people maintain better comfort and health than expected, and families often find a steady routine with the care team. Talk with your doctor about what your personal outlook might look like, including which findings on imaging and exams matter most for your child’s future.
Long-term effects
Closed iniencephaly is a severe, congenital condition that most often leads to loss of the pregnancy or death shortly after birth. A small number of children survive, but they typically face complex, lifelong medical needs and marked developmental challenges. Long-term effects vary widely, reflecting how many body systems are involved. When considering what lies ahead, families and care teams focus on comfort, quality of life, and monitoring for complications over time.
Many pregnancies end in stillbirth or shortly after birth due to the severity of closed iniencephaly. Rare survivors often have ongoing, serious medical challenges.
Profound developmental delay and learning difficulties are common. Communication and independent daily activities are usually very limited over time.
Abnormal airway shape and weak muscle control can cause chronic breathing problems. Recurrent chest infections and hospitalizations are possible.
Swallowing difficulties can lead to poor weight gain and risk of food or liquid entering the lungs. Long-term tube feeding may be required.
How is it to live with Closed iniencephaly?
Living with closed iniencephaly is not part of most families’ plans, and the reality is profoundly medical and time-sensitive. This neural tube defect is typically diagnosed during pregnancy; many pregnancies sadly end in miscarriage or stillbirth, and newborns who survive delivery often face severe, life-limiting complications that require intensive care. Day to day, parents and loved ones navigate complex decisions, frequent medical visits, and anticipatory grief, while also needing psychosocial support, bereavement resources, and compassionate guidance from their care team. For many, connecting with perinatal palliative care and support groups helps create space for love, memory-making, and informed choices in an otherwise overwhelming experience.
Treatment and drugs
Treatment for closed iniencephaly focuses on supportive care, because this rare neural tube condition is typically severe and not surgically curable. Care teams aim to stabilize breathing and circulation at birth, manage feeding and comfort, and address complications such as difficulty maintaining an open airway or problems with body temperature. If other structural differences are present, some procedures may be considered on a case-by-case basis to ease symptoms, but outcomes vary widely. Supportive care can make a real difference in how you feel day to day. Families often work closely with neonatology, neurology, genetics, and palliative care to plan next steps that align with their goals and values.
Non-drug treatment
Care for closed iniencephaly centers on preparation, comfort, and family support from pregnancy through the newborn period. Beyond prescriptions, supportive therapies can help guide decisions and ease symptoms. Plans are tailored to the baby’s specific features and to your goals and values.
Detailed ultrasound and MRI map the baby’s spine, head, and neck. Prenatal signs of closed iniencephaly on ultrasound can help plan care and delivery.
High‑risk obstetric teams monitor you and the baby closely. Visits often include targeted scans and discussions about options.
Birth at a center with neonatal and surgical specialists is usually recommended. Planning ahead helps ensure equipment and the right team are ready at delivery.
Palliative care focuses on easing pain, breathing effort, and distress. Families can choose skin‑to‑skin time, gentle positioning, and memory‑making moments.
Your genes may have an impact on how drugs work for you
Some medicines work differently from person to person because genes can change how fast the body absorbs, breaks down, or clears a drug. In prenatal and neonatal care around closed iniencephaly, genetics can influence dosing needs, side‑effect risks, and responses to pain control or supportive therapies.
Pharmacological treatments
There isn’t a medication that can reverse the spinal and skull formation changes seen in closed iniencephaly; drug therapy focuses on comfort and treating complications if a baby is born alive. Drugs that target symptoms directly are called symptomatic treatments. Care teams individualize medicines to support breathing, reduce pain, prevent infection, or control seizures, often around procedures or surgery if that is pursued. In pregnancy, early signs of closed iniencephaly on prenatal ultrasound guide delivery planning and supportive care rather than drug treatment.
No medicine can correct closed iniencephaly itself. Medications are used for symptom relief and short-term stabilization if needed.
Taking folic acid before conception and in early pregnancy lowers the risk of neural tube defects. Typical doses are 400–800 micrograms (0.4–0.8 mg) daily, with 4–5 mg daily prescribed for high‑risk pregnancies.
If seizures occur in closed iniencephaly, newborns may receive levetiracetam or phenobarbital. Doses are carefully adjusted and babies are monitored for sleepiness or breathing changes.
Acetaminophen or small doses of morphine can ease discomfort, especially around procedures. Teams watch for side effects like constipation or drowsiness.
Genetic influences
Most pregnancies affected by Closed iniencephaly appear to be sporadic, with no clear inherited pattern in the family. Genetics is only one piece of the puzzle, but changes in chromosomes or in genes that guide early spine and skull formation have been reported in a small number of cases. These may include rare chromosome differences and, less commonly, a change in a single gene involved in neural tube development, yet there isn’t one specific “Closed iniencephaly gene.” Because most cases are not directly inherited, the chance of Closed iniencephaly occurring again in the same family is generally low, though it may be slightly higher than in the general population. When families want to explore possible genetic causes of Closed iniencephaly, a genetics team may consider testing for chromosome changes and discuss how folate-related pathways and other factors can shape risk. Preconception folic acid, careful diabetes management, and reviewing medications before pregnancy remain important, since genes and environment often work together early in development.
Is Closed iniencephaly genetic?
Genetics plays a major role in Closed iniencephaly, though most cases are sporadic. Variants affecting neural tube formation, folate pathways, and vertebral development can increase risk. Family history slightly raises recurrence risk; preconception folic acid reduces risk.
Pharmacogenetics—how genetics influence drug effects
There is no medicine that treats closed iniencephaly itself; care focuses on prenatal counseling, delivery planning, and, in rare situations, surgery for associated issues. Because treatment options for closed iniencephaly center on the pregnant person’s health, genetics mainly matters through how the parent’s body handles medicines taken in pregnancy, such as anti‑seizure drugs or folic acid supplements. Genes can influence how quickly you process certain medicines, which can affect the dose needed and the chance of side effects. This information isn’t used to treat the fetus, but it can guide safer choices and dosing for the pregnant person when medication is necessary. Many other factors—overall health, other prescriptions, and the changes of pregnancy—also shape drug response, so pharmacogenetic testing isn’t routine and is used case by case. Folic acid before and during early pregnancy lowers the risk of neural tube defects in general, and your care team may adjust supplement doses based on overall risk rather than genetic test results.
Interactions with other conditions
In pregnancies affected by Closed iniencephaly, doctors often find other birth differences alongside it, especially in the brain and spine, and sometimes the heart, kidneys, or limbs. Some conditions share “underlying mechanisms,” such as early neural tube formation and folate pathways, which helps explain why multiple neural tube defects can appear together. Chromosomal syndromes like trisomy 13 or 18 have been reported in some pregnancies with iniencephaly, so teams may discuss genetic testing and a detailed ultrasound. Maternal health conditions including preexisting diabetes, higher body weight, low folate status, and certain seizure medicines can raise the chance of neural tube defects and may coexist in the same pregnancy, shaping counseling and monitoring plans. Prenatal signs of closed iniencephaly on ultrasound often prompt a careful check for other organ differences to map out the safest path forward. If the pregnant person has another condition, coordinated care between obstetrics, genetics, neonatology, and, when needed, cardiology or neurosurgery helps guide decisions before and after birth.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described newborns with severe changes in head and neck shape that were not compatible with long-term survival. Midwives and physicians in earlier centuries recorded rare births with the head bent sharply backward and the neck appearing very short or absent. Families and communities once noticed patterns in certain regions or time periods, but these events were sporadic and heartbreaking, and many details were lost because infants often died shortly after birth.
First described in the medical literature as a distinct pattern in the early 20th century, closed iniencephaly was set apart from other neural tube defects by its extreme backward bending of the spine at the neck and upper back, along with skull and soft tissue changes that “close” the defect. Initially understood only through symptoms, later case reports and autopsy studies clarified that the defect involves early development of the brain, spinal cord, and vertebrae. Over time, descriptions became more precise as clinicians recognized that closed iniencephaly differs from open forms where brain tissue is exposed.
With each decade, improvements in prenatal care and imaging changed how closed iniencephaly was recognized. Ultrasound in the late 20th century allowed doctors to see the characteristic head‑neck position and spinal curvature before birth. Later, detailed imaging and pathology studies helped explain why delivery could be difficult and why associated features—such as limited skull growth or chest and limb differences—sometimes appear together. Despite evolving definitions, the core picture has remained consistent: a rare, severe neural tube defect with a distinctive posture and a very poor prognosis.
From early theories to modern research, the story of closed iniencephaly has also followed broader advances in understanding neural tube defects. Historical reports sometimes grouped these conditions together. Now, clinicians separate closed iniencephaly from anencephaly and other forms based on anatomy and whether the defect is covered by skin and soft tissue. Awareness of folate’s role in early pregnancy led to public health measures like folic acid supplementation, which reduced many neural tube defects overall, though closed iniencephaly remains uncommon.
Today, the history of closed iniencephaly informs counseling and care. Knowing the condition’s history helps explain why early prenatal screening, detailed ultrasound, and discussions about delivery planning are emphasized. It also underscores why research continues into prevention and the earliest steps of fetal development, building on generations of careful observation and the experiences of families and clinicians who faced this rare diagnosis.